Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: Natl India
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Generic Pharma

Sun Pharmaceutical Industries Ltd

+ Add to Watchlist

SUNP:IN

1,006.30 INR 63.25 6.71%

As of 06:06:37 ET on 03/04/2015.

Snapshot for Sun Pharmaceutical Industries Ltd (SUNP)

Open: 946.90 Day's Range: 937.80 - 1,035.95 Volume: 8,289,221
Previous Close: 943.05 52wk Range: 552.50 - 1,035.95 1-Yr Rtn: +62.76%

Stock Chart for SUNP

No chart data available.
  • SUNP:IN 1,006.30
  • 1D
  • 1M
  • 1Y
943.05
Interactive SUNP Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for SUNP

Current P/E Ratio (ttm) 66.3046
Estimated P/E(03/2015) 33.7175
Relative P/E vs. SENSEX 3.2295
Earnings Per Share (INR) (ttm) 15.1769
Est. EPS (INR) (03/2015) 29.8450
Est. PEG Ratio 1.3694
Market Cap (M INR) 2,084,152.06
Shares Outstanding (M) 2,071.10
30 Day Average Volume 2,421,000
Price/Book (mrq) 11.2508
Price/Sale (ttm) 12.9612
Dividend Indicated Gross Yield 0.15%
Cash Dividend (INR) 1.5000
Dividend Ex-Date 09/11/2014
5 Year Dividend Growth 1.76%
Next Earnings Announcement 05/29/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for SUNP

  • Revenue
  • Net Income (M/INR)
  • Profit Margin (%)

Company Profile & Key Executives for SUNP

Sun Pharmaceutical Industries Limited manufactures and markets pharmaceuticals for domestic and international distribution. The Company's pharmaceutical portfolio includes drugs in the areas of diabetes, cardiology, neurology, psychiatry and gastroenterology.

Kalyana Sundaram SubramanianChief Executive OfficerDilip Shantilal ShanghviManaging Director/Founder
Uday BaldotaChief Financial OfficerSudhir Vrundavandas ValiaExecutive Director
More Company Profile & Key Executives for SUNP

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil